Schedule 13G ownership disclosure
Viridian Therapeutics Inc
Security class unavailable · CUSIP: 92790C104
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 426,162
- Percent of class
- 10.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-21-000280
- Form type
- SC 13G
- Filer
- Point72 Asset Management, L.P.
- CIK
- CIK 1603466
- Filed
- Feb 16, 2021
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership